Abstract
This economic evaluation investigates the health outcomes and costs associated with use of monoclonal antibodies for treatment of SARS-CoV-2 in 14 scenarios stratified by age, vaccination status, and source of infection.
All Keywords
【초록키워드】 Treatment, SARS-CoV-2, vaccination, monoclonal antibody, outcome, Health, age, source of infection, stratified, 【제목키워드】 SARS-CoV-2, prevention, Mitigation, Estimated,
【초록키워드】 Treatment, SARS-CoV-2, vaccination, monoclonal antibody, outcome, Health, age, source of infection, stratified, 【제목키워드】 SARS-CoV-2, prevention, Mitigation, Estimated,
{{{ 추상적인 }}}
이 경제적 평가는 연령, 백신 접종 상태 및 감염원에 따라 계층화된 14개 시나리오에서 SARS-CoV-2 치료를 위한 단일클론 항체 사용과 관련된 건강 결과 및 비용을 조사합니다.